The way an individual interprets language is influenced by many factors, including culture, background, education, training, and personal biases. This article will look at the approaches Drug Safety and Pharmacovigilance teams can take to resolve these issues, allowing the pharmaceutical industry to receive the benefits of operating in a multicultural environment.
Clinical trials are complex undertakings, with complex planning required. Success or failure is often determined long before the trial even gets underway. Biorasi’s quintessential guide to clinical trial planning helps program managers and operations directors identify and resolve the sticking points that can risk the timely completion of their clinical trials and programs.
Read how integrating CDISC standards at the very beginning of a clinical trial, research organizations can leverage powerful analysis tools to cut through much of the tedious, time consuming, and expensive manual work typically associated with collecting, cleaning, analyzing, quality controlling, and reporting clinical study data.
The current limitations on the use of immunotherapy drugs could be swept away thanks to the development of immune checkpoint inhibitors. They block disruptive proteins that limit the body’s natural immune response and stop T-Cells from destroying cancer cells. Some of the biggest factors stopping the more widespread use of these drugs are the limitations of current standards in effectively measuring how well they work. Read how improvements in the methods used for immuno-oncology drug trials could benefit both researchers and patients.
A Sponsor was facing difficulties with tracking payment details, critical for financial transparency and requirement details. Read how eClinicalGPS played an integral role in their mission to modernize clinical investigator payment processes.
For this biotech, the big challenge was both a lack of expertise and resources needed to manage registration of trials and posting results.TrialScope provided a proven solution that optimizes the e ciency of disclosure activities,
maximizes trial data transparency, and fosters more informed, engaged patients through open research sharing.
Web-based survey tools can be extremely beneficial to pharmaceutical companies and CROs for reducing site selection cycle time as well as operational costs (not to mention the opportunity costs). But what sets site feasibility, and other clinical forms, apart from other nonclinical survey types?
Unsure if a REMS is needed during product development? This article will answer that question and give guidance if implementing a REMS is necessary.
It is difficult to quantify the soft costs of managing a clinical trial. One factor guilty of contributing to spiraling soft costs is time. Download Almac’s case study that demonstrates how Almac’s One Clinical Trial Supply Solution helped a pharmaceutical company streamline its clinical trial operations, resulting in time and cost savings.
As companies are looking to reduce their supplier base and shifting towards more strategic relationships with key suppliers to achieve economies of scale, learn how contract suppliers can benefit from developing strategic partnerships with other vendors and operating as one entity.
|
|
|
|
|
|
|
|
|